Van Andel Research Institute. Laboratory for Translational Parkinson's Disease Research R&D Centers

Research in Patrik Brundin’s laboratory focuses on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s disease. The group’s mission is to understand neurodegenerative diseases and develop new therapies that are of benefit to patients and their caregivers.

Headquarters: United States